Melissa M. Cushing

NewYork–Presbyterian Hospital — United States

Medicine · Health Sciences

34h-index5.4kcitations234works2.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Blood transfusion and management(59), Trauma, Hemostasis, Coagulopathy, Resuscitation(43), SARS-CoV-2 and COVID-19 Research(37), COVID-19 Clinical Research Studies(32), Hematopoietic Stem Cell Transplantation(30)

Publications232 total

Divining the future by counting empty bags—Does the number of transfused blood products predict resuscitation futility in injured adults?
Transfusion·2025· 1 cited
Comparative analysis of ABO titers in traditional cryoprecipitate versus INTERCEPT Fibrinogen Complex
Transfusion and Apheresis Science·2025
Comparative evaluation of five tacrolimus assays in transplant recipients: implications for optimizing therapeutic drug monitoring
Frontiers in Transplantation·2025· 1 citedOpen Access
Revisiting whole blood transfusion for the massively bleeding patient: The origins of resistance to change
Transfusion·2025· 1 citedOpen Access
Changing epidemiology of SARS-CoV-2 positivity rates in a diverse population of children and adults during variant evolution and progressive vaccination eligibility in New York City
BMC Infectious Diseases·2025Open Access
Systematic literature review and meta-analysis on the safety of fibrinogen concentrate versus cryoprecipitate in bleeding surgical patients
Blood·2025Open Access
Changing epidemiology of SARS-CoV-2 positivity rates in a diverse population of children and adults during variant evolution and progressive vaccination eligibility in New York City
2025Open Access
Accelerating time from result to clinical action: impact of an automated critical results reporting system
Clinical Chemistry and Laboratory Medicine (CCLM)·2025
Sankey diagrams: A simple, intuitive way to visualize and analyze complex, convoluted transfusion medicine operations data
Transfusion·2025· 1 citedOpen Access
Abstract CT206: ICAM-1 directed chimeric antigen receptor (CAR) T cells (AIC100) in patients with advanced thyroid cancers: Clinical and translational data from the phase 1 dose escalation study
Cancer Research·2025
Transfusion service staff and anesthesiologists prefer pathogen‐reduced cryoprecipitate over conventional cryoprecipitated antihemophilic factor
Transfusion·2025Open Access
Prothrombin Complex Concentrate vs Frozen Plasma for Coagulopathic Bleeding in Cardiac Surgery
JAMA·2025· 27 citedOpen Access
New device, old algorithm? Bridging generations in perioperative coagulation management
British Journal of Anaesthesia·2025
Preanalytical Considerations of Handling Suspected Creutzfeldt–Jakob Disease Specimens Within the Clinical Pathology Laboratories: A Survey-Based Approach
Journal of Clinical Medicine·2025· 1 citedOpen Access
The incompatible match for transfusion medicine fellowships
Transfusion·2025Open Access
List of Contributors
Elsevier eBooks·2024Open Access
Platelet Products
Elsevier eBooks·2024
Comparison of five tacrolimus measurement methods underscore the need for a standardized method to improve clinical outcomes
American Journal of Clinical Pathology·2024· 2 citedOpen Access
Trial Of Pathogen-reduced Cryoprecipitate vs. Cryoprecipitated AHF to Lower Operative Transfusions (TOP-CLOT): study protocol for a single center, prospective, cluster randomized trial
Trials·2024· 2 citedOpen Access
Safety and efficacy of AIC100 chimeric antigen receptor (CAR) T-cell therapy in patients with advanced thyroid cancers: Results from the phase 1 study.
Journal of Clinical Oncology·2024· 8 cited
page 1 of 12Next →

Frequent Co-authors

Lars F. Westblade(11), Paul M. Ness(8), Zhen Zhao(8), Priya Velu(7), Massimo Loda(6), Arryn Craney(6), Hanna Rennert(6), He S. Yang(5), Sabrina Racine‐Brzostek(5), Per Johan Klasse(5), Amy Chadburn(5), Ruchika Goel(5), Marshall J. Glesby(4), Jim Yee(4), Zhengming Chen(4), Karen E. King(4), Steven M. Frank(4), Ljiljana V. Vasović(4), Marianne E. Nellis(4), Beth H. Shaz(4)